Advertisement

Topics

Forest Laboratories, Inc. Company Profile

09:11 EDT 20th October 2018 | BioPortfolio

Forest Laboratories (NYSE: FRX) is a U.S.-based pharmaceutical company with a long track record of building partnerships and developing and marketing products that make a positive difference in people’s lives. In addition to its well-established franchises in therapeutic areas of the central nervous and cardiovascular systems, Forest’s current pipeline includes product candidates in all stages of development and across a wide range of therapeutic areas. The Company is headquartered in New York, NY. To learn more about Forest Laboratories, visit www.frx.com.


News Articles [371 Associated News Articles listed on BioPortfolio]

Forest Blow, PTV News: Apr 08, 2010

FDA panel says no to Forest Laboratories' lung drug Daxas

Forest City Seats New Independent Directors

"We are thrilled to welcome our new independent directors to the Forest CityBoard," said David LaRue, President and Chief Executive Officer of Forest Read more...

Wake Forest researchers create advanced brain organoid to model strokes, screen drugs

(Wake Forest Baptist Medical Center) Wake Forest Institute for Regenerative Medicine scientists have developed a 3D brain organoid that could have potential applications in drug discovery and disease ...

Joint paper identifies one of Mesoamerica's last intact forest blocks

(Wildlife Conservation Society) The Wildlife Conservation Society (WCS) and Yale University have created a plan to preserve one of the last intact forest strongholds for the jaguar and other iconic sp...

Heterotrophic cultivation of Auxenochlorella protothecoides using forest biomass as a feedstock for sustainable biodiesel production

The aim of this work was to establish a process for the heterotrophic growth of green microalgae using forest biomass hydrolysates. To provide a carbon source for the growth of the green microalgae, t...

Everything you wanted to know about wildland forest fires but were afraid to ask

How the forest copes with the summer heat

(University of Basel) Between April and August this year, Switzerland and central Europe have experienced the driest summer season since 1864. Especially the forest seems to suffer from this dry spell...

Wake Forest Baptist awarded $8 Million to study intervention for diabetes

(Wake Forest Baptist Medical Center) The National Institutes of Health (NIH) has awarded $8 million to Wake Forest Baptist Medical Center to study cognitive decline and impairment in older adults with...

PubMed Articles [540 Associated PubMed Articles listed on BioPortfolio]

Losing sight of the Forest for the trees: Why clinical laboratories need to perform their own interference studies.

Laboratory Safety in Parasitology Laboratory.

Working in a laboratory is very difficult and needs special attention. Laboratory workers can be exposed to numerous potential hazards including chemical, biological, physical, and radioactive. That i...

NDVI-derived forest area change and its driving factors in China.

China harbors diversified forest types, from tropical rainforest to boreal coniferous forest, and has implemented large-scale reforestation/afforestation programs over the past several decades. Howeve...

Cs and K annual fluxes in a cropland and forest ecosystems twenty-four years after the Chernobyl accident.

Biological cycles of the Chernobyl originated cesium-137 (Cs, radiocesium) and the natural potassium (K) in oak, birch, and pine forest, and wheat cropland in Russian Federation, approximately 500 k...

Moisture content estimation of forest litter based on remote sensing data.

As a fine fuel, forest litter plays an important role in fire danger rating systems, so forest litter moisture data are necessary and meaningful for fire risk management and prevention. An optical rem...

Clinical Trials [294 Associated Clinical Trials listed on BioPortfolio]

Prevention of Malaria With Dihydroartemisinine + Piperaquine for Forest Rangers

The purpose of the study is to assess if the antimalarial drugs Dihydroartemisinine + Piperaquine (DP) are effective in preventing malaria infection for forest ranger

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects Under Fasting Condition

- Objective: - To compare the rate and extent of absorption of Citalopram Hydrobromide Tablets 40 mg: Test Product: Citalopram Hydrobromide Tablets 40 mg manufactured b...

Companies [1037 Associated Companies listed on BioPortfolio]

Forest Laboratories, Inc.

Forest Laboratories (NYSE: FRX) is a U.S.-based pharmaceutical company with a long track record of building partnerships and developing and marketing products that make a positive...

Forest Laboratories

Forest Laboratories develops, manufactures and sells both branded and generic forms of ethical products which require a physician's prescription, as well as non-prescription pharmaceutical products so...

Forest Laboratories, Inc. and Almirall, S.A.

Forest Laboratories' (NYSE: FRX) longstanding global partnerships and track record developing and marketing pharmaceutical products in the United States have yielded its well-esta...

Forest Laboratories, Inc. and Furiex Pharmaceuticals, Inc.

Forest Laboratories (NYSE: FRX) is a leading, fully integrated, specialty pharmaceutical company largely focused on the United States market. Forest markets a portfolio of branded...

Forest Laboratories, Inc. and Clinical Data, Inc.

Forest Laboratories’ (NYSE: FRX) longstanding global partnerships and track record developing and marketing pharmaceutical products in the United States have yielded its well...

More Information about "Forest Laboratories, Inc." on BioPortfolio

We have published hundreds of Forest Laboratories, Inc. news stories on BioPortfolio along with dozens of Forest Laboratories, Inc. Clinical Trials and PubMed Articles about Forest Laboratories, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Forest Laboratories, Inc. Companies in our database. You can also find out about relevant Forest Laboratories, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...


Corporate Database Quicklinks



Searches Linking to this Company Record